China Biologic Products (CBPO) Reports Q3 EPS of $0.96

China Biologic Products (NASDAQ: CBPO) reported Q3 EPS of $0.96, versus $1.38 reported last year. Revenue for the quarter came in at $119.1 million versus the consensus estimate of $99.6 million.

• Board of Directors Approves $100 Million Share Repurchase Program
• The Company reiterates its previously revised full year 2018 forecast.

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49